2.98
3.11%
+0.09
Arbutus Biopharma Corp (ABUS) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
53.95%
2.145
|
4.658 | 4.651 | 6.687 | 6.245 |
Operating Expenses
|
12.68%
22.89
|
26.22 | 23.04 | 24.10 | 28.81 |
Interest Income/Expense |
4.35%
0.044
|
0.046 | 0.171 | 0.198 | 0.309 |
Benefits Costs and Expenses |
380.81%
-69.53
|
24.76 | 21.75 | 23.03 | -75.85 |
Costs And Expenses |
7.87%
26.71
|
24.76 | 21.75 | 23.03 | 28.62 |
Operating Income/Loss |
3.76%
-20.75
|
-21.56 | -18.39 | -17.41 | -22.56 |
Nonoperating Income/Loss |
1.31%
1.435
|
1.454 | 1.291 | 1.074 | 0.63 |
Income/Loss From Continuing Operations Before Tax |
456.54%
71.68
|
-20.10 | -17.09 | -16.34 | 82.10 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
3.94%
-19.31
|
-20.10 | -17.09 | -16.34 | -21.93 |
Net Income/Loss
|
3.94%
-19.31
|
-20.10 | -17.09 | -16.34 | -21.93 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.48%
0.8751
|
167.51 | 166.06 | 161.64 | 1.5533 |
Diluted Average Shares |
99.48%
0.8751
|
167.51 | 166.06 | 161.64 | 1.5533 |
Basic Earnings Per Share |
0.00%
-0.12
|
-0.12 | -0.10 | -0.10 | -0.14 |
Diluted Earnings Per Share |
0.00%
-0.12
|
-0.12 | -0.10 | -0.10 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):